Search by Drug Name or NDC
NDC 16714-0767-01 Cefixime 200 mg/5mL Details
Cefixime 200 mg/5mL
Cefixime is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NorthStar RxLLC. The primary component is CEFIXIME.
MedlinePlus Drug Summary
Cefixime is used to treat certain infections caused by bacteria such as bronchitis (infection of the airway tubes leading to the lungs); gonorrhea (a sexually transmitted disease); and infections of the ears, throat, tonsils, and urinary tract. Cefixime is in a class of medications called cephalosporin antibiotics. It works by killing bacteria. Antibiotics such as cefixime will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 16714-0767-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Cefixime
Product Information
| NDC | 16714-0767 |
|---|---|
| Product ID | 16714-767_f15f86c9-5ebe-800a-e053-2995a90af842 |
| Associated GPIs | 02300060001920 |
| GCN Sequence Number | 044428 |
| GCN Sequence Number Description | cefixime SUSP RECON 200 MG/5ML ORAL |
| HIC3 | W1Y |
| HIC3 Description | CEPHALOSPORIN ANTIBIOTICS - 3RD GENERATION |
| GCN | 92368 |
| HICL Sequence Number | 003999 |
| HICL Sequence Number Description | CEFIXIME |
| Brand/Generic | Generic |
| Proprietary Name | Cefixime |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | cefixime |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | POWDER, FOR SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/5mL |
| Substance Name | CEFIXIME |
| Labeler Name | NorthStar RxLLC |
| Pharmaceutical Class | Cephalosporin Antibacterial [EPC], Cephalosporins [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206938 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 16714-0767-01 (16714076701)
| NDC Package Code | 16714-767-01 |
|---|---|
| Billing NDC | 16714076701 |
| Package | 50 mL in 1 BOTTLE (16714-767-01) |
| Marketing Start Date | 2018-05-11 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 4.86236 |
| Pricing Unit | ML |
| Effective Date | 2023-02-22 |
| NDC Description | CEFIXIME 200 MG/5 ML SUSP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-01-31 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis